Physical and functional characterization of the human LGI1 gene and its possible role in glioma development

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Dietmar Krex - , Department of Neurosurgery (Author)
  • Martin Hauses - , TUD Dresden University of Technology (Author)
  • Hella Appelt - , TUD Dresden University of Technology (Author)
  • Brigitte Mohr - , Department of Internal Medicine I (Author)
  • Gerhard Ehninger - , TUD Dresden University of Technology (Author)
  • Hans Konrad Schackert - , TUD Dresden University of Technology (Author)
  • Gabriele Schackert - , TUD Dresden University of Technology (Author)

Abstract

The human gene termed LGI1 (leucine-rich gene - glioma inactivated) has been isolated recently, and is supposed to be an additional candidate tumor suppressor gene involved in the formation and progression of glioblastoma multiforme [Chernova et al. (1998) Oncogene 17:2873-2881]. To test this hypothesis and to complete the characterization of the gene, we performed various detailed studies on the genomic structure, the mRNA expression level, the integrity of the cDNA, and retroviral gene transfer into LGI1-deficient cell lines. Two single nucleotide polymorphisms in the promotor region and a highly polymorphic intragenic microsatellite repeat between exon 4 and 5 were found. Phylogenetic sequence analysis techniques were applied, which showed functional relationships between LGI1 and TRK and SLIT protein families that are known to be involved in development and maintenance of the nervous system. Fluorescence in situ hybridization (FISH) analysis showed LGI1 to be present on 10q24 in each of 11 glioma-derived cell lines evaluated. Sequence analysis of the LGI1 transcript did not detect any mutation. Relative amounts of LGI1 mRNA copy numbers as measured by the real-time fluorescence detection LightCycler technology differed more than three orders of magnitude and were significantly reduced in 10 of 11 cell lines. Retroviral gene transfer into LGI1-deficient glioma-derived cell lines could not substantiate any difference to control infected cultures regarding growth rate, S phase transition, and maintenance of marker gene expression. The strong homology to proteins involved in development, differentiation, or maintenance of the nervous system provides evidence for a function of the LGI1 protein in neural tissue. The observation that translocation or deletion of the LGI1 locus or mutation of the coding sequence of the LGI1 mRNA is not a frequent event in malignant glioma cell lines suggests that epigenetic factors lead to substantial differences in the amount of LGI1 mRNA expression. In addition, that the effect is lacking after retroviral gene transfer in cell culture suggests that binding of some kind of a ligand is essential for its biological activity.

Details

Original languageEnglish
Pages (from-to)255-266
Number of pages12
JournalActa neuropathologica
Volume103
Issue number3
Publication statusPublished - 2002
Peer-reviewedYes

External IDs

PubMed 11907806

Keywords

Keywords

  • Gene, Glioblastoma, LGI1, Pathogenesis, Tumor suppressor